Cancer Treatment and Research Communications — Journal Profile & Submission Links
Elsevier BV · ISSN-L 2468-2942
Source-backed journal profile with OpenAlex metadata and links to official submission resources for Cancer Treatment and Research Communications.
This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.
Official links
- Journal homepage
- www.journals.elsevier.com/cancer-treatment-and-research-comm…
- Author guidelines
- www.sciencedirect.com/journal/cancer-treatment-and-research-…
- Submission portal
- www.editorialmanager.com/ctc/default.aspx
Catalog scope notes
Cancer Treatment and Research Communications is an international peer-reviewed journal dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches in all tumor types; cancer biology; molecular carcinogenesis; cancer genetics and genomics; cancer stem cells; molecular and cellular oncology; systems biology; immuno-oncology; chemoprevention strategies; gene and antisense therapy; the pathology of cancer, prognostic and predictive markers; drug sensitivity and resistance and novel treatment strategies to impact patient care. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice. Peer reviewed types of articles include Original Reports, Reviews and Editorials. The journal will not consider Case Reports or articles related to Cancer Policy.
Catalog source: scimago. This is not a copy of the publisher's author instructions.
Submission & timeline
- Submission portal
- www.editorialmanager.com/ctc/default.aspx
- Average review time
- Information not currently available.
- Acceptance rate
- Information not currently available.
- Article types accepted
- Information not currently available.
- Publication frequency
- Information not currently available.
General pre-submission checks for medical manuscripts
Generic checklist only — not journal-specific requirements.
- Confirm scope fit and intended article type on the official journal site.
- Abstract structure matches the journal's current requirements.
- Ethics approval and trial registration statements are complete.
- Informed consent and patient privacy statements are in place.
- Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
- Reference style and citation limits per official guidelines.
- Figures and tables meet resolution, labeling, and count limits.
- Cover letter addresses novelty, fit, and required declarations.
- Conflicts of interest statement included.
- Funding statement included.
- Data availability statement included when required.